|
1
|
Rosenberg I: Summary comments:
Epidemiological and methodological problems in determining
nutritional status of older persons. Am J Clin Nutr. 50:1231–1233.
1989. View Article : Google Scholar
|
|
2
|
Harimoto N, Yoshizumi T, Shimokawa M,
Sakata K, Kimura K, Itoh S, Ikegami T, Ikeda T, Shirabe K and
Maehara Y: Sarcopenia is a poor prognostic factor following hepatic
resection in patients aged 70 years and older with hepatocellular
carcinoma. Hepatol Res. 46:1247–1255. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suzuki Y, Okamoto T, Fujishita T, Katsura
M, Akamine T, Takamori S, Morodomi Y, Tagawa T, Shoji F and Maehara
Y: Clinical implications of sarcopenia in patients undergoing
complete resection for early non-small cell lung cancer. Lung
Cancer. 101:92–97. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hirasawa Y, Nakashima J, Yunaiyama D,
Sugihara T, Gondo T, Nakagami Y, Horiguchi Y, Ohno Y, Namiki K,
Ohori M, et al: Sarcopenia as a novel preoperative prognostic
predictor for survival in patients with bladder cancer undergoing
radical cystectomy. Ann Surg Oncol. 23(Suppl 5): S1048–S1054. 2016.
View Article : Google Scholar
|
|
5
|
Tan BH, Birdsell LA, Martin L, Baracos VE
and Fearon KC: Sarcopenia in an overweight or obese patient is an
adverse prognostic factor in pancreatic cancer. Clin Cancer Res.
15:6973–6979. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sabel MS, Lee J, Cai S, Englesbe MJ,
Holcombe S and Wang S: Sarcopenia as a prognostic factor among
patients with stage III melanoma. Ann Surg Oncol. 18:3579–3585.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M,
Tokunaga R, Kurashige J, Hiyoshi Y, Iwagami S, Yoshida N, Yoshida
M, et al: Sarcopenia is a negative prognostic factor after curative
resection of colorectal cancer. Ann Surg Oncol. 22:2663–2668. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M,
Tokunaga R, Kurashige J, Hiyoshi Y, Iwagami S, Yoshida N, Watanabe
M and Baba H: Negative impact of skeletal muscle loss after
systemic chemotherapy in patients with unresectable colorectal
cancer. PLoS One. 10:e01297422015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhuang CL, Huang DD, Pang WY, Zhou CJ,
Wang SL, Lou N, Ma LL, Yu Z and Shen X: Sarcopenia is an
independent predictor of severe postoperative complications and
long-term survival after radical gastrectomy for gastric cancer:
Analysis from a large-scale cohort. Medicine (Baltimore).
95:e31642016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aoyama T, Sato T, Segami K, Maezawa Y,
Kano K, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, et
al: Risk factors for the loss of lean body mass after gastrectomy
for gastric cancer. Ann Surg Oncol. 23:1963–1970. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamaoka Y, Fujitani K, Tsujinaka T,
Yamamoto K, Hirao M and Sekimoto M: Skeletal muscle loss after
total gastrectomy, exacerbated by adjuvant chemotherapy. Gastric
Cancer. 18:382–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aoyama T, Kawabe T, Fujikawa H, Hayashi T,
Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, et al:
Loss of lean body mass as an independent risk factor for
continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann
Surg Oncol. 22:2560–2566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aoyama T, Kawabe T, Hirohito F, Hayashi T,
Yamada T, Tsuchida K, Sato T, Oshima T, Rino Y, Masuda M, et al:
Body composition analysis within 1 month after gastrectomy for
gastric cancer. Gastric Cancer. 19:645–650. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takachi K, Doki Y, Ishikawa O, Miyashiro
I, Sasaki Y, Ohigashi H, Murata K, Nakajima H, Hosoda H, Kangawa K,
et al: Postoperative ghrelin levels and delayed recovery from body
weight loss after distal or total gastrectomy. J Surg Res. 130:1–7.
2016. View Article : Google Scholar
|
|
15
|
Joglekar S, Nau PN and Mezhir JJ: The
impact of sarcopenia on survival and complications in surgical
oncology: A review of the current literature. J Surg Oncol.
112:503–509. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Richards CH, Roxburgh CS, MacMillan MT,
Isswiasi S, Robertson EG, Guthrie GK, Horgan PG and McMillan DC:
The relationships between body composition and the systemic
inflammatory response in patients with primary operable colorectal
cancer. PLoS One. 7:e418832012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maggio M, de Vita F, Lauretani F, Buttò V,
Bondi G, Cattabiani C, Nouvenne A, Meschi T, Dall'Aglio E and Ceda
GP: IGF-1, the cross road of the nutritional, inflammatory and
hormonal pathways to frailty. Nutrients. 5:4184–4205. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee HH, Park JM, Song KY, Choi MG and Park
CH: Survival impact of postoperative body mass index in gastric
cancer patients undergoing gastrectomy. Eur J Cancer. 52:129–137.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kubo H, Komatsu S, Ichikawa D, Kawaguchi
T, Kosuga T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H and
Otsuji E: Impact of body weight loss on recurrence after curative
gastrectomy for gastric cancer. Anticancer Res. 36:807–813.
2016.PubMed/NCBI
|
|
20
|
Aoyama T, Yoshikawa T, Shirai J, Hayashi
T, Yamada T, Tsuchida K, Hasegawa S, Cho H, Yukawa N, Oshima T, et
al: Body weight loss after surgery is an independent risk factor
for continuation of S-1 adjuvant chemotherapy for gastric cancer.
Ann Surg Oncol. 20:2000–2006. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hatao F, Chen KY, Wu JM, Wang MY, Aikou S,
Onoyama H, Shimizu N, Fukatsu K, Seto Y and Lin MT: Randomized
controlled clinical trial assessing the effects of oral nutritional
supplements in postoperative gastric cancer patients. Langenbecks
Arch Surg. 402:203–211. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Imamura H, Nishikawa K, Kishi K, Inoue K,
Matsuyama J, Akamaru Y, Kimura Y, Tamura S, Kawabata R, Kawada J,
et al: Effects of an oral elemental nutritional supplement on
post-gastrectomy body weight loss in gastric cancer patients: A
randomized controlled clinical trial. Ann Surg Oncol. 23:2928–2935.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Adachi S, Takiguchi S, Okada K, Yamamoto
K, Yamasaki M, Miyata H, Nakajima K, Fujiwara Y, Hosoda H, Kangawa
K, et al: Effects of ghrelin administration after total
gastrectomy: A prospective, randomized, placebo-controlled phase II
study. Gastroenterology. 138:1312–1320. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takiguchi S, Hiura Y, Takahashi T,
Kurokawa Y, Yamasaki M, Nakajima K, Miyata H, Mori M, Hosoda H,
Kangawa K and Doki Y: Effect of rikkunshito, a Japanese herbal
medicine, on gastrointestinal symptoms and ghrelin levels in
gastric cancer patients after gastrectomy. Gastric Cancer.
16:167–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fujitsuka N, Asakawa A, Morinaga A,
Amitani MS, Amitani H, Katsuura G, Sawada Y, Sudo Y, Uezono Y,
Mochiki E, et al: Increased ghrelin signaling prolongs survival in
mouse models of human aging through activation of sirtuin1. Mol
Psychiatry. 21:1613–1623. 2016. View Article : Google Scholar : PubMed/NCBI
|
